Since two weeks ago until now, there have been no additional cases.
Jakarta (ANTARA) – The number of cases of atypical progressive acute kidney injury in children has not increased in the past two weeks, Health Ministry spokesperson Mohammad Syahril informed on Thursday.
“Since two weeks ago until now, there have been no additional cases. This is the result of a joint effort, where there have been no additional cases and no deaths,” Syahril said at a webinar on the management of acute kidney injury, which was followed from Jakarta.
Currently, there are 11 patients undergoing treatment for acute kidney failure at the National Central General Hospital Dr. Cipto Mangunkusumo (RSCM) Jakarta, he added.
“We hope that the 11 patients who are still being treated at RSCM can recover after being given the Fomepizole antidote that we have brought in,” he said.
The Ministry of Health recorded a total of 324 cases of acute kidney injury in 27 provinces, Syahril informed. The number of cases has remained unchanged since November 2, 2022, he said.
The ministry, in collaboration with the Food and Drug Supervisory Agency (BPOM), examined the alleged link between ethylene glycol (EG) and diethylene glycol (DEG) contamination in syrup drugs and kidney failure, he added.
Health Minister Budi Gunadi Sadikin earlier said that cases of acute kidney injury in Indonesia dropped dramatically after the government temporarily stopped the distribution and use of syrup drugs.
In addition, the Ministry of Health tested the use of Fomepizole on 10 acute kidney injury patients at RSCM Jakarta and the drug was found effective in restoring their health.
After the number of cases of acute kidney injury declined, the government announced a list of safe-to-use syrup drugs based on safety and product quality testing conducted by BPOM on October 23.
Related news: No additional acute kidney failure cases recorded in past fortnight
Related news: Health Ministry open to pharmacopeia revision